Latest AI and machine learning research in other cancers for healthcare professionals.
Heart failure (HF) remains a major cause of morbidity, mortality, impaired quality of life and healthcare expenditure worldwide. The global burden of HF continues to increase due to population aging, improved survival, and the growing prevalence of cardiovascular, renal, and metabolic comorbidities. Simultaneously, the pace of scientific progress in HF has accelerated considerably. Recent advances...
Neoantigen vaccines have rekindled interest in therapeutic cancer vaccination, yet their clinical efficacy remains constrained by imperfect antigen prioritization, incomplete modeling of immunogenicity, tumor heterogeneity, and immune evasion mechanisms. Current computational pipelines are dominated by discriminative models that rank pre-existing mutant peptides based on features related to HLA bi...
OBJECTIVES: Lymphoma is a prevalent hematologic malignancy with complex pathogenesis involving dysregulated signaling pathways and high treatment resi...
PURPOSE: With AI tools being increasingly utilized for medical inquiries, this study evaluated the agreement between clinicians, text-only clinicians,...
Machine learning methods have been growing in prominence across all areas of medicine. In pathology, recent advances in deep learning (DL) have enable...
BACKGROUND: Dedicated service for Barrett's oesophagus (BO) surveillance may be more effective than conventional service, according to some single cen...
Solid tumors, the most prevalent form of malignancy, pose therapeutic challenges distinct from hematologic malignancies due to their complex biology, ...
BACKGROUND: Artificial intelligence (AI) is reshaping clinical decision support systems (CDSSs). In acute and critical care, nurses provide continuous...
The therapeutic landscape of haematological malignancies has evolved rapidly with the introduction of targeted therapies, immunotherapies, and cell-ba...
BACKGROUND: Tumor-Specific Peptides (TSPs) and Tumor-associated Overexpressed Proteins (TOPs) are promising biomarkers for cancer diagnosis and monito...
BACKGROUND/AIM: Lung adenocarcinoma (LUAD) exhibits substantial molecular heterogeneity and variable clinical outcomes, highlighting the need for biom...
The cancer-testis antigen MAGE-A4 is an attractive immunotherapy target due to its high expression in various malignancies and restricted expression i...
Thyroid cancer is one of the most prevalent malignancies of the endocrine system, comprising various subtypes such as papillary thyroid carcinoma (PTC...
Oxidative stress plays a significant regulatory role in tumor immune responses and can influence the efficacy of immunotherapy. Accordingly, therapeut...
Fusion transcripts are hybrid RNA molecules generated through genomic rearrangements or RNA-level fusion mechanisms. They represent important molecula...
Tertiary lymphoid structure (TLS) correlates with improved prognosis in melanoma. The role of solute carrier family 52 member A2 (SLC52A2) in mediatin...
OBJECTIVES: Oral submucous fibrosis (OSF) is a chronic and progressive potentially malignant disorder with an increased risk of transformation to oral...
OBJECTIVE: Breast ultrasound imaging is widely used for the early detection of malignant breast lesions. Although deep learning models have shown stro...
Oral squamous cell carcinoma (OSCC) continues to be associated with a poor prognosis despite recent advances in surgical and adjuvant treatment. Altho...
Immunological biomarkers are increasingly relevant for personalized cancer treatment, but peripheral blood-derived biomarkers are not yet used to guid...